Results 221 to 230 of about 15,580 (252)
Some of the next articles are maybe not open access.
Eczema Area and Severity Index (EASI): A New Tool to Evaluate Atopic Dermatitis
Journal of the European Academy of Dermatology and Venereology, 1998J M Hanifin, M Graeber
exaly +2 more sources
Expert Review of Clinical Immunology
Atopic dermatitis (AD) is a chronic inflammatory skin condition prevalent among children worldwide. Systemic inflammation is a key factor in its pathophysiology. Correlating blood markers with Eczema Area and Severity Index (EASI) can reveal information about the severity and activity of the disorder, allowing for more focused treatment.A retrospective
Janadi Ashinshani Karawita +1 more
exaly +3 more sources
Atopic dermatitis (AD) is a chronic inflammatory skin condition prevalent among children worldwide. Systemic inflammation is a key factor in its pathophysiology. Correlating blood markers with Eczema Area and Severity Index (EASI) can reveal information about the severity and activity of the disorder, allowing for more focused treatment.A retrospective
Janadi Ashinshani Karawita +1 more
exaly +3 more sources
Development of an Eczema Area and Severity Index Atlas for Diverse Skin Types
Dermatitis®Abstract: Background: Current guidance for using Eczema Area and Severity Index (EASI) implementation is limited to lighter skin phototypes. We developed an EASI lesion severity atlas and refined guidance for investigators and clinicians to
Jonathan I. Silverberg +2 more
openaire +2 more sources
Pediatric Dermatology, 2018
AbstractBackground/ObjectivesAtopic dermatitis is a common, chronic, debilitating disease. Poor adherence to treatment is the most important preventable contributor to adverse outcomes. Thus, improving adherence can improve patient outcomes. Text message reminders with embedded condition‐specific information have been shown to improve pediatric ...
Laura E Levin +2 more
exaly +3 more sources
AbstractBackground/ObjectivesAtopic dermatitis is a common, chronic, debilitating disease. Poor adherence to treatment is the most important preventable contributor to adverse outcomes. Thus, improving adherence can improve patient outcomes. Text message reminders with embedded condition‐specific information have been shown to improve pediatric ...
Laura E Levin +2 more
exaly +3 more sources
Dermatitis®
Abstract: Background: The Eczema Area and Severity Index (EASI) has been suggested to show a good to ...
Jose Maria Villa-Gonzalez +21 more
openaire +2 more sources
Abstract: Background: The Eczema Area and Severity Index (EASI) has been suggested to show a good to ...
Jose Maria Villa-Gonzalez +21 more
openaire +2 more sources
Dermatitis®, 2023
Objective: Patients with atopic dermatitis (AD) experience decreased quality of life (QoL). Here we describe the relationship between severity and QoL-related scores in patients with moderate-to-severe AD treated with dupilumab.
Russo F. +7 more
openaire +4 more sources
Objective: Patients with atopic dermatitis (AD) experience decreased quality of life (QoL). Here we describe the relationship between severity and QoL-related scores in patients with moderate-to-severe AD treated with dupilumab.
Russo F. +7 more
openaire +4 more sources
British Journal of Dermatology, 2023
Abstract Atopic dermatitis (AD) often has a significant impact on the quality of life (QoL) of those affected and their families. Validated QoL and visual analogue scales (VAS) are widely used in dermatology to measure the impact of this common disease. As part of a larger prospective study, we subanalysed data to look at the correlation
Pavan Sambi +5 more
openaire +1 more source
Abstract Atopic dermatitis (AD) often has a significant impact on the quality of life (QoL) of those affected and their families. Validated QoL and visual analogue scales (VAS) are widely used in dermatology to measure the impact of this common disease. As part of a larger prospective study, we subanalysed data to look at the correlation
Pavan Sambi +5 more
openaire +1 more source
Pediatric dermatology, 2011
The Self-Administered Eczema Area and Severity Index (SA-EASI) is one of the few patient based atopic dermatitis (AD) disease activity scores and was found to be highly correlated with the EASI. Correlation with other frequently used scoring methods has not been investigated.
Sara G A, van Velsen +4 more
openaire +1 more source
The Self-Administered Eczema Area and Severity Index (SA-EASI) is one of the few patient based atopic dermatitis (AD) disease activity scores and was found to be highly correlated with the EASI. Correlation with other frequently used scoring methods has not been investigated.
Sara G A, van Velsen +4 more
openaire +1 more source
British Journal of Dermatology, 2004
To validate the Eczema Area and Severity Index (EASI) by assessing its internal consistency, reliability and sensitivity to change and by correlating it to other efficacy parameters.Three short-term and two long-term double-blind, randomized, controlled trials, performed in 138 study centres in Europe, South Africa, Australia, New Zealand, and North ...
N, Barbier +8 more
openaire +2 more sources
To validate the Eczema Area and Severity Index (EASI) by assessing its internal consistency, reliability and sensitivity to change and by correlating it to other efficacy parameters.Three short-term and two long-term double-blind, randomized, controlled trials, performed in 138 study centres in Europe, South Africa, Australia, New Zealand, and North ...
N, Barbier +8 more
openaire +2 more sources
British Journal of Dermatology
Abstract To date, no clinical scoring systems exist to quantify atopic dermatitis (AD) disease manifestations in relation to solar radiation exposure. This is clinically relevant, as an estimated 1.4–16% of cases of AD constitute photoaggravated atopic dermatitis. Here, we introduce a modification of the Eczema Area and Severity Index
John Warner-Levy +8 more
openaire +1 more source
Abstract To date, no clinical scoring systems exist to quantify atopic dermatitis (AD) disease manifestations in relation to solar radiation exposure. This is clinically relevant, as an estimated 1.4–16% of cases of AD constitute photoaggravated atopic dermatitis. Here, we introduce a modification of the Eczema Area and Severity Index
John Warner-Levy +8 more
openaire +1 more source

